Chris Savile
Chief Executive Officer chez WILLOW BIOSCIENCES INC.
Fortune : 69 758 $ au 31/03/2024
Profil
Chris Savile is currently the President, Chief Executive Officer & Director at Willow Biosciences, Inc. Prior to this, he held the position of Executive Director-Commercial Operations at Precigen, Inc. from 2015 to 2019.
Before that, he was an Associate Director-Business Development at Codexis, Inc. from 2014 to 2015.
Dr. Savile obtained his doctorate degree from McGill University in 2005.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
WILLOW BIOSCIENCES INC.
0,74% | 02/04/2024 | 917 870 ( 0,74% ) | 69 758 $ | 31/03/2024 |
Postes actifs de Chris Savile
| Sociétés | Poste | Début |
|---|---|---|
| WILLOW BIOSCIENCES INC. | Chief Executive Officer | 28/03/2023 |
Anciens postes connus de Chris Savile
| Sociétés | Poste | Fin |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 01/01/2019 |
| CODEXIS, INC. | Corporate Officer/Principal | 01/04/2015 |
Formation de Chris Savile
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CODEXIS, INC. | Process Industries |
| PRECIGEN, INC. | Health Technology |
| WILLOW BIOSCIENCES INC. | Commercial Services |
